Pluristem Therapeutics Inc (NASDAQ:PSTI)

2.46
Delayed Data
As of Jul 02
 -0.05 / -1.99%
Today’s Change
2.32
Today|||52-Week Range
3.78
-1.60%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Pluristem Therapeutics Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +103.25% increase from the last price of 2.46.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Pluristem Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$93.0K
Reporting Date
Jun 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.78%
 
 
 
 
 
 
Growthannually 14.88%
 
 
 
 
 
 

Sales

Growthquarterly -2.11%
 
 
 
 
 
 
Growthannually 1.23%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account